Antibodies to Sniff out Deadly Ebola Hastily and Efficiently Is Coming Soon
2 mins read

Antibodies to Sniff out Deadly Ebola Hastily and Efficiently Is Coming Soon

Ebola – the deadly virus that kills 90% of the people who get infected with it, has ended up being a real headache for World Health Organization (WHO) as well as scientists across the globe. Up to now, there are no particular methods that can identify this deadly virus quickly. But, soon the scenario is going to change, as scientists are developing new Antibodies that can sniff out the noxious Ebola more rapidly and efficiently.

A team of international researchers, while presenting their preliminary report on February 6 at the American Society for Microbiology Biothreats Summit have revealed that soon there wills a diagnosis program for Ebola which will make out this monotonous virus as soon as possible.

Currently, people have to wait for a full day to get the diagnosis reports of Ebola’s presence in the DNA of patients’ blood samples. The diagnosis of Ebola not only need access to a specialized laboratory but also sometimes take more than 24-hour to submit reports. But soon, simpler and speedier methods for diagnosing of Ebola will be available, stated the report presented by the scientists at the conference of American Society for Microbiology Biothreats.

The scientists draw on antibodies – the dedicated proteins that clutch onto and mark virus particles in the body. According to the research team from of the University of Nevada, Reno School of Medicine, Antibodies strongly engrossed to the virus and can map out it quickly in a blood sample.

The antibodies work is quite similar to those of pregnancy test in the home. According to the report, only within 10 or 15 minutes of patting a blood sample against a piece of paper, it will confirm about the positivity of the virus through a colored line. The trick is similar to the method of confirming pregnancy with the pregnancy kit at home.

However, for now, the method is under development as it failed to deliver accurate results until a prolonged sickness of the patient, said Haley DeMers, an immunologist at the University of Nevada, Reno School of Medicine.